Previously, TGF-β1 polymorphisms have been suggested as a risk factor for AERD development, and TGF-β1 was associated with the prevalence of CRS in AERD patients, but not in ATA patients [21]. The gene discussed is TGFB1; the disease is congenital rubella syndrome.